GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ferozsons Laboratories Ltd (KAR:FEROZ) » Definitions » E10

Ferozsons Laboratories (KAR:FEROZ) E10 : ₨20.30 (As of Dec. 2024)


View and export this data going back to 1960. Start your Free Trial

What is Ferozsons Laboratories E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ferozsons Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was ₨3.460. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₨20.30 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Ferozsons Laboratories's average E10 Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-26), Ferozsons Laboratories's current stock price is ₨309.90. Ferozsons Laboratories's E10 for the quarter that ended in Dec. 2024 was ₨20.30. Ferozsons Laboratories's Shiller PE Ratio of today is 15.27.

During the past 10 years, the highest Shiller PE Ratio of Ferozsons Laboratories was 18.52. The lowest was 7.24. And the median was 12.28.


Ferozsons Laboratories E10 Historical Data

The historical data trend for Ferozsons Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ferozsons Laboratories E10 Chart

Ferozsons Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 20.23

Ferozsons Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.95 20.21 20.23 20.45 20.30

Competitive Comparison of Ferozsons Laboratories's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ferozsons Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ferozsons Laboratories's Shiller PE Ratio falls into.



Ferozsons Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ferozsons Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=3.46/133.1571*133.1571
=3.460

Current CPI (Dec. 2024) = 133.1571.

Ferozsons Laboratories Quarterly Data

per share eps CPI Adj_EPS
201503 6.743 99.621 9.013
201506 7.507 100.684 9.928
201509 17.111 100.392 22.696
201512 17.431 99.792 23.259
201603 11.847 100.470 15.701
201606 4.317 101.688 5.653
201609 4.938 101.861 6.455
201612 3.618 101.863 4.730
201703 6.153 102.862 7.965
201706 -1.979 103.349 -2.550
201709 1.438 104.136 1.839
201712 -0.701 104.011 -0.897
201803 0.500 105.290 0.632
201806 -1.076 106.317 -1.348
201809 1.632 106.507 2.040
201812 0.840 105.998 1.055
201903 0.361 107.251 0.448
201906 1.785 108.070 2.199
201909 1.785 108.329 2.194
201912 1.783 108.420 2.190
202003 2.367 108.902 2.894
202006 3.658 108.767 4.478
202009 2.683 109.815 3.253
202012 8.250 109.897 9.996
202103 6.500 111.754 7.745
202106 9.558 114.631 11.103
202109 6.290 115.734 7.237
202112 6.740 117.630 7.630
202203 6.470 121.301 7.102
202206 -2.610 125.017 -2.780
202209 2.910 125.227 3.094
202212 2.640 125.222 2.807
202303 0.840 127.348 0.878
202306 -0.140 128.729 -0.145
202309 6.050 129.860 6.204
202312 2.340 129.419 2.408
202403 3.100 131.776 3.132
202406 4.220 132.554 4.239
202409 5.070 133.029 5.075
202412 3.460 133.157 3.460

Add all the adjusted EPS together and divide 10 will get our e10.


Ferozsons Laboratories  (KAR:FEROZ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ferozsons Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=309.90/20.30
=15.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Shiller P/E Ratio of Ferozsons Laboratories was 18.52. The lowest was 7.24. And the median was 12.28.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ferozsons Laboratories E10 Related Terms

Thank you for viewing the detailed overview of Ferozsons Laboratories's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ferozsons Laboratories Business Description

Traded in Other Exchanges
N/A
Address
5.K.M - Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.

Ferozsons Laboratories Headlines

No Headlines